FdaApplication
NDA 202157
Identifiers
- fda_app_no: NDA202157
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS UNIT III |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE | LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE | 150MG;200MG;300MG | TABLET;ORAL |
1 product